Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 185,179 | 65,215 | 36,111 | 36,705 | -3,058 |
| Depreciation Amortization | 3,799 | 4,579 | 4,887 | 4,638 | 5,063 |
| Income taxes - deferred | -11,227 | -5,685 | 3,146 | -4,921 | -1,007 |
| Accounts receivable | -128,016 | -40,191 | -13,082 | -13,482 | -15,122 |
| Other Working Capital | 282,795 | -28,227 | -43,982 | 20,046 | -20,301 |
| Other Operating Activity | 146,779 | 43,383 | 20,863 | 16,770 | 18,966 |
| Operating Cash Flow | $479,309 | $39,074 | $7,943 | $59,756 | $-15,459 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -77,126 | -31,847 | -19,670 | N/A | N/A |
| PPE Investments | -127,466 | -10,607 | -5,591 | -11,896 | -12,628 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 852 |
| Purchase Sale Intangibles | -164 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -164 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-204,756 | $-42,454 | $-25,261 | $-11,896 | $-11,776 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 33,227 | 2,109 | 18,898 | 28,636 | 45,462 |
| Debt Issued | 10,162 | 1,457 | N/A | N/A | N/A |
| Debt Repayment | -4,345 | N/A | N/A | 4,440 | N/A |
| Common Stock Issued | 1,999 | N/A | 85,368 | 1,692 | 315 |
| Other Financing Activity | 551,523 | -1,829 | -40,086 | -36,110 | -17,993 |
| Financing Cash Flow | $592,566 | $1,737 | $64,180 | $-1,342 | $27,784 |
| Exchange Rate Effect | 27,207 | -649 | -4,656 | 4,005 | -2,092 |
| Beginning Cash Position | 155,878 | 158,170 | 115,964 | 65,441 | 63,834 |
| End Cash Position | 1,050,204 | 155,878 | 158,170 | 115,964 | 62,434 |
| Net Cash Flow | $894,326 | $-2,292 | $42,206 | $50,523 | $-1,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 479,309 | 39,074 | 7,943 | 59,756 | -15,459 |
| Capital Expenditure | -127,486 | -10,628 | -5,613 | -11,915 | -12,654 |
| Free Cash Flow | 351,823 | 28,446 | 2,330 | 47,841 | -28,113 |